WHO ICTRP trial
Study on the safety and efficacy of the ketogenic diets for stage IV advanced…
JPRN-UMIN000039925 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000039925 |
|---|---|
| Public title | Study on the safety and efficacy of the ketogenic diets for stage IV advanced and recurrent cancer patients. |
| Scientific title | Study on the safety and efficacy of the ketogenic diets for stage IV advanced and recurrent cancer patients. - KDAC study |
| Primary sponsor | Tama-Nanbu Regional Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation Department of Surgery |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase I |
| Countries | Japan |
| Conditions | All types of cancer for which PET-CT examination is indicated |
| Interventions | Intervention period: 1 year The criteria for a ketogenic diet are as follows: Daily carbohydrate intake: 5% or less of energy intake Daily EPA intake: 2g or more Daily protein intake: Weight x 1.6g or more Daily chain fatty acid intake: 40g… |
| Registration date | Mar 31, 2020 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: